Construct: ORF ccsbBroadEn_07730
Construct Description:
- Construct Type:
- ORF
- Other Identifiers:
- ORF011646.1_s300c1, BRDN0000385358
- DNA Barcode:
- None
- Epitope Tag:
- None
- Notes:
- No stop codon in insert
Originally Annotated References:
- Gene:
- LILRA2 (11027)
Vector Information:
- Vector Backbone:
- pDONR223
- Pol II Cassette 1:
- n/a
- Pol II Cassette 2:
- n/a
- Selection Marker:
- n/a
- Visible Reporter:
- n/a
- Epitope Tag:
- n/a
Current transcripts matched by this ORF:
| Taxon | Gene | Symbol | Description | Transcript | Nuc. Match %[?]A simple nucleotide-based global alignment percentage, calculated as follows: total nt. matches ---------------------------------- aligned length (incl. gaps) |
Prot. Match %[?]A simple amino acid-based global alignment percentage, calculated as follows: total aa. matches ---------------------------------- aligned length (incl. gaps) |
Match Diffs[?]This field may contain sequence annotations in HGVS format. For more information about HGVS annotations, please refer to the HGVS Quick Reference Guide. | |
|---|---|---|---|---|---|---|---|---|
| 1 | human | 11027 | LILRA2 | leukocyte immunoglobulin li... | NM_006866.4 | 99.9% | 99.7% | 404C>T |
| 2 | human | 11027 | LILRA2 | leukocyte immunoglobulin li... | NM_001290270.1 | 97.3% | 97.2% | 33_34ins36;368C>T |
| 3 | human | 11027 | LILRA2 | leukocyte immunoglobulin li... | XM_011526387.1 | 97.3% | 97.2% | 33_34ins36;368C>T |
| 4 | human | 11027 | LILRA2 | leukocyte immunoglobulin li... | NM_001130917.3 | 96.4% | 96% | 404C>T;1256_1306del |
| 5 | human | 11027 | LILRA2 | leukocyte immunoglobulin li... | XM_011526385.1 | 96.4% | 96% | 404C>T;1256_1306del |
| 6 | human | 11027 | LILRA2 | leukocyte immunoglobulin li... | NM_001290271.2 | 90.9% | 82.5% | (many diffs) |
| 7 | human | 11027 | LILRA2 | leukocyte immunoglobulin li... | XM_006722986.1 | 90.9% | 82.5% | (many diffs) |
| 8 | human | 11027 | LILRA2 | leukocyte immunoglobulin li... | XM_011526386.1 | 88.5% | 80.2% | (many diffs) |
| 9 | human | 11027 | LILRA2 | leukocyte immunoglobulin li... | XM_011526388.1 | 87.5% | 86.8% | (many diffs) |
| 10 | human | 11024 | LILRA1 | leukocyte immunoglobulin li... | NM_006863.4 | 84.4% | 75.9% | (many diffs) |
| 11 | human | 10288 | LILRB2 | leukocyte immunoglobulin li... | NM_001278406.2 | 83.7% | 69.3% | (many diffs) |
| 12 | human | 10859 | LILRB1 | leukocyte immunoglobulin li... | NM_001278399.2 | 83.1% | 74.3% | (many diffs) |
| 13 | human | 11026 | LILRA3 | leukocyte immunoglobulin li... | NM_006865.4 | 82.7% | 73.3% | (many diffs) |
| 14 | human | 11024 | LILRA1 | leukocyte immunoglobulin li... | NM_001278319.1 | 81.7% | 72.5% | (many diffs) |
| 15 | human | 10288 | LILRB2 | leukocyte immunoglobulin li... | NM_001278405.2 | 80.1% | 67.9% | (many diffs) |
| 16 | human | 11027 | LILRA2 | leukocyte immunoglobulin li... | XM_011526390.1 | 78.4% | 69.5% | 404C>T;949_950ins35;1098_1099ins265 |
| 17 | human | 10859 | LILRB1 | leukocyte immunoglobulin li... | XM_017026192.1 | 77.3% | 69% | (many diffs) |
| 18 | human | 11027 | LILRA2 | leukocyte immunoglobulin li... | XM_017026224.1 | 70.9% | 63.2% | (many diffs) |
| 19 | human | 11026 | LILRA3 | leukocyte immunoglobulin li... | NM_001172654.2 | 69.9% | 61.3% | (many diffs) |
| 20 | human | 11027 | LILRA2 | leukocyte immunoglobulin li... | XM_011526389.1 | 69.2% | 59.8% | (many diffs) |
| 21 | human | 10288 | LILRB2 | leukocyte immunoglobulin li... | NM_001080978.4 | 68.8% | 59.2% | (many diffs) |
| 22 | human | 10288 | LILRB2 | leukocyte immunoglobulin li... | NM_001278403.2 | 68.8% | 59.2% | (many diffs) |
| 23 | human | 10859 | LILRB1 | leukocyte immunoglobulin li... | XM_011526336.2 | 68.8% | 60% | (many diffs) |
| 24 | human | 10288 | LILRB2 | leukocyte immunoglobulin li... | NM_005874.5 | 68.7% | 59.1% | (many diffs) |
| 25 | human | 10859 | LILRB1 | leukocyte immunoglobulin li... | XM_017026191.1 | 68.7% | 60.1% | (many diffs) |
| 26 | human | 10859 | LILRB1 | leukocyte immunoglobulin li... | XR_935716.2 | 67.4% | (many diffs) | |
| 27 | human | 10859 | LILRB1 | leukocyte immunoglobulin li... | XM_011526335.2 | 67.1% | 58.1% | (many diffs) |
| 28 | human | 10859 | LILRB1 | leukocyte immunoglobulin li... | NM_001278398.2 | 64.9% | 56.9% | (many diffs) |
| 29 | human | 10859 | LILRB1 | leukocyte immunoglobulin li... | NM_006669.6 | 63.3% | 55.2% | (many diffs) |
| 30 | human | 10859 | LILRB1 | leukocyte immunoglobulin li... | XM_017026185.1 | 63.3% | 55.2% | (many diffs) |
| 31 | human | 10859 | LILRB1 | leukocyte immunoglobulin li... | NM_001081638.3 | 63.2% | 55.2% | (many diffs) |
| 32 | human | 10859 | LILRB1 | leukocyte immunoglobulin li... | NM_001081639.3 | 63.2% | 55.1% | (many diffs) |
| 33 | human | 10859 | LILRB1 | leukocyte immunoglobulin li... | NM_001081637.2 | 63.2% | 55.2% | (many diffs) |
| 34 | human | 11024 | LILRA1 | leukocyte immunoglobulin li... | NR_103503.1 | 62.9% | (many diffs) | |
| 35 | human | 10859 | LILRB1 | leukocyte immunoglobulin li... | XM_017026183.2 | 62.4% | 54.3% | (many diffs) |
| 36 | human | 10859 | LILRB1 | leukocyte immunoglobulin li... | XM_017026182.2 | 62.3% | 54.4% | (many diffs) |
| 37 | human | 10859 | LILRB1 | leukocyte immunoglobulin li... | XM_017026184.2 | 61.9% | 53.4% | (many diffs) |
| 38 | human | 10859 | LILRB1 | leukocyte immunoglobulin li... | XM_011526332.3 | 61.9% | 53.5% | (many diffs) |
| 39 | human | 10859 | LILRB1 | leukocyte immunoglobulin li... | XM_011526331.2 | 61.8% | 53.4% | (many diffs) |
| 40 | human | 10859 | LILRB1 | leukocyte immunoglobulin li... | XM_017026190.1 | 61.7% | 53.8% | (many diffs) |
| 41 | human | 10859 | LILRB1 | leukocyte immunoglobulin li... | XM_017026188.1 | 61.7% | 53.8% | (many diffs) |
| 42 | human | 10859 | LILRB1 | leukocyte immunoglobulin li... | XM_017026189.1 | 61.7% | 53.7% | (many diffs) |
| 43 | human | 10859 | LILRB1 | leukocyte immunoglobulin li... | XM_017026186.1 | 61.6% | 53.8% | (many diffs) |
| 44 | human | 10859 | LILRB1 | leukocyte immunoglobulin li... | XM_017026187.1 | 61.6% | 53.8% | (many diffs) |
| 45 | human | 11027 | LILRA2 | leukocyte immunoglobulin li... | XM_011526391.1 | 57.2% | 45.1% | 404C>T;652_653ins332;801_802ins265 |
| 46 | human | 11024 | LILRA1 | leukocyte immunoglobulin li... | NR_103502.1 | 56.3% | (many diffs) | |
| 47 | human | 11024 | LILRA1 | leukocyte immunoglobulin li... | NM_001278318.2 | 55.7% | 48% | (many diffs) |
| 48 | human | 10288 | LILRB2 | leukocyte immunoglobulin li... | NM_001278404.2 | 52.1% | 44.3% | (many diffs) |
| 49 | human | 10859 | LILRB1 | leukocyte immunoglobulin li... | NR_103518.2 | 45.1% | (many diffs) | |
| 50 | human | 10288 | LILRB2 | leukocyte immunoglobulin li... | NR_103521.3 | 43.5% | (many diffs) | |
| 51 | human | 10859 | LILRB1 | leukocyte immunoglobulin li... | XR_002958244.1 | 37% | (many diffs) | |
| 52 | human | 10859 | LILRB1 | leukocyte immunoglobulin li... | XR_001753590.2 | 37% | (many diffs) | |
| 53 | human | 10859 | LILRB1 | leukocyte immunoglobulin li... | XR_001753591.1 | 36.7% | (many diffs) | |
| 54 | human | 11024 | LILRA1 | leukocyte immunoglobulin li... | NR_103501.2 | 36.6% | (many diffs) |
Sequence Information
Note: uppercase bases indicate empirically verified sequence.
- ORF start:
- 66
- ORF end:
- 1464
- ORF length:
- 1398
- Sequence:
-
1 gttcgttgca acaaattgat gagcaatgct tttttataat gccaaCTTTG TACAAAAAAG 61 TTGGCATGAC CCCCATCCTC ACGGTCCTGA TCTGTCTCGG GCTGAGTCTG GGCCCCAGGA 121 CCCACGTGCA GGCAGGGCAC CTCCCCAAGC CCACCCTCTG GGCTGAGCCA GGCTCTGTGA 181 TCATCCAGGG AAGTCCTGTG ACCCTCAGGT GTCAGGGGAG CCTTCAGGCT GAGGAGTACC 241 ATCTATATAG GGAAAACAAA TCAGCATCCT GGGTTAGACG GATACAAGAG CCTGGGAAGA 301 ATGGCCAGTT CCCCATCCCA TCCATCACCT GGGAACACGC AGGGCGGTAT CACTGTCAGT 361 ACTACAGCCA CAATCACTCA TCAGAGTACA GTGACCCCCT GGAGCTGGTG GTGACAGGAG 421 CCTACAGCAA ACCCACCCTC TCAGCTCTGC CCAGCCCTGT GGTGACCTTA GGAGGGAACG 481 TGACCCTCCA GTGTGTCTCA CAGGTGGCAT TTGACGGCTT CATTCTGTGT AAGGAAGGAG 541 AAGATGAACA CCCACAACGC CTGAACTCCC ATTCCCATGC CCGTGGGTGG TCCTGGGCCA 601 TCTTCTCCGT GGGCCCCGTG AGCCCGAGTC GCAGGTGGTC GTACAGGTGC TATGCTTATG 661 ACTCGAACTC TCCCTATGTG TGGTCTCTAC CCAGTGATCT CCTGGAGCTC CTGGTCCCAG 721 GTGTTTCTAA GAAGCCATCA CTCTCAGTGC AGCCAGGTCC TATGGTGGCC CCTGGGGAGA 781 GCCTGACCCT CCAGTGTGTC TCTGATGTCG GCTACGACAG ATTTGTTCTG TATAAGGAGG 841 GAGAACGTGA CTTCCTCCAG CGCCCTGGTT GGCAGCCCCA GGCTGGGCTC TCCCAGGCCA 901 ACTTCACCCT GGGCCCTGTG AGCCCCTCCC ACGGGGGCCA GTACAGATGC TACAGTGCAC 961 ACAACCTCTC CTCCGAGTGG TCGGCCCCCA GTGACCCCCT GGACATCCTG ATCACAGGAC 1021 AGTTCTATGA CAGACCCTCT CTCTCGGTGC AGCCGGTCCC CACAGTAGCC CCAGGAAAGA 1081 ACGTGACCCT GCTGTGTCAG TCACGGGGGC AGTTCCACAC TTTCCTTCTG ACCAAGGAGG 1141 GGGCAGGCCA TCCCCCACTG CATCTGAGAT CAGAGCACCA AGCTCAGCAG AACCAGGCTG 1201 AATTCCGCAT GGGTCCTGTG ACCTCAGCCC ACGTGGGGAC CTACAGATGC TACAGCTCAC 1261 TCAGCTCCAA CCCCTACCTG CTGTCTCTCC CCAGTGACCC CCTGGAGCTC GTGGTCTCAG 1321 CATCCCTAGG CCAACACCCC CAGGATTACA CAGTGGAGAA TCTCATCCGC ATGGGTGTGG 1381 CTGGCTTGGT CCTGGTGGTC CTCGGGATTC TGCTATTTGA GGCTCAGCAC AGCCAGAGAA 1441 GCCTACAAGA TGCAGCCGGG AGGTGCCCAA CTTTCTTGTA CAAAGTtggc attataagaa 1501 agcattgctt atcaatttgt tgcaacgaac